David Lubeck is an Ophthalmology physician affiliated with Shirley Ryan AbilityLab. OpenAlex indexes 42 publications with 780 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2640 183rd St
Homewood, IL 604302914
Telephone
708-798-6633Registry record last updated 21 Jul 2022.
Clinical trials
- Safety and Efficacy of Corneal Crosslinking Using the PXL-Platinum 330 for Eyes With Corneal Ectatic Conditions
Sponsor: Arbor Center for Eye Care
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year202520 payments$13,447openpaymentsdata.cms.gov ↗
- Nova Eye, Inc.Program year20253 payments
- Beaver-Visitec International, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
67.1%Corticosteroid32.1%Prednisolone Acetate96%Fluorometholone4%Part D≥327 patientsFluoroquinolone Antibacterial23%Ciprofloxacin Hcl100%Part D≥307 patients+ 6 more classes in this area
Musculoskeletal
21.5%Cyclooxygenase Inhibitor20.7%Ketorolac Tromethamine100%Part D≥272 patientsNonsteroidal Anti-inflammatory Drug0.8%Diclofenac Sodium100%Part D<11 patientsAnti-infectives
7.7%Fluoroquinolone Antibacterial4.1%Moxifloxacin100%Part D<11 patientsMacrolide2%Erythromycin100%Part D≥12 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”